Legend Biotech Corp - ADR
NASDAQ:LEGN 4:00:00 PM EDT
| Market Cap (Intraday) | 6.53B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 54.6 |
| 10-Day MA | $34.46 |
| 50-Day MA | $32.47 |
| 200-Day MA | $37.63 |
Legend Biotech Corp - ADR Stock, NASDAQ:LEGN
2101 Cottontail Lane, Somerset, New Jersey 08873
United States of America
Phone: +1.737.317.5050
Number of Employees: 2609
Description
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.